Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalizing Antiplatelet Therapy in PAD
NCT04269863Unknown
- Sponsor
- Unity Health Toronto
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of aspirin in Peripheral Arterial Disease (PAD) (2 arms), sponsored by Unity Health Toronto. Primary endpoints: PAD disease progression at 1 year and Development of Critical limb ischemia at 1 year. Status: unknown.
02
Drugs
aspirin
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT04269863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04269863.